Saltar al contenido principal

Biomarkers in Critical Care, An Issue of Critical Care Clinics

  • 1 Edición, Volumen 36-1 - 26 de noviembre de 2019
  • Última edición
  • Editor: Mitchell Levy
  • Idioma: Inglés

This issue of Critical Care Clinics, guest edited by Dr. Mitchell M. Levy, focuses on Biomarkers in Critical Care. This is one of four issues each year selected by the series… Leer más

Descripción

This issue of Critical Care Clinics, guest edited by Dr. Mitchell M. Levy, focuses on Biomarkers in Critical Care. This is one of four issues each year selected by the series consulting editor, Dr. John Kellum. Articles in this issue include, but are not limited to: The History of Biomarkers; Biomarkers for Identifying Infection; Procalcitonin: Where Are We Now?; Soluble TREM-1: Diagnosis or Prognosis?; Lubricin as a Biomarker in Sepsis; Check Point Inhibitors and Their Role in Immunosuppression in Sepsis; Metabolomics and the Microbiome as Biomarkers in Sepsis; Lactate: Where Are We Now?; Predicting Renal Dysfunction; Biomarkers in the Evolution of ARDS; Biomarkers and RV Dysfunction; Biomarkers and Precision Medicine: State of the Art; The Use of Biomarkers for Population Homogeneity in Clinical Trials; and The Future of Biomarkers.

Detalles del producto

  • Edición: 1
  • Última edición
  • Volumen: 36-1
  • Publicado: 28 de noviembre de 2019
  • Idioma: Inglés

Sobre el editor

ML

Mitchell Levy

Afiliaciones y experiencia
Systemwide Director, Critical Care Medicine Lifespan Health; Professor of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Warren Alpert Medical School at Brown University, Providence, Rhode Island